References
- Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996;14:3126–32.
- Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. ; 2015. Guidelines on testicular cancer. s.l. EAU European Association of Urology, 2015. Chs. 5.7-5.9. Available from: https://uroweb.org/guideline/testicular-cancer/#5.
- Dieckmann KP, Heinemann V, Frey U, Pichlmeier U. and German Testicular Cancer Study Group. How harmful is contralateral testicular biopsy? – an analysis of serial imaging studies and a prospective evaluation of surgical complications. Eur Urol 2005;48:662–72.
- Petersen PM, Giwercman A, Daugaard G, Rørth M, Petersen JH Skakkeaek NE, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 2002;20:1537–43.
- Kier MG, Lauritsen J, Almstrup K, Mortensen MS, Toft BG, Rajpert-De Meyts E, et al. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study. Ann Oncol 2015;26:737–42.
- Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 2007;51:175–83.
- Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS Oldenburg J. SWENOTECA, et al. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncol 2015;54:493–9.
- DATECA: dansk testis cancer udvalg. Retningslinjer for testiscancer 2014. [Online] DaTeCa, 2014. http://ducg.dk/dateca-testiscancer/kliniske-retningslinjer/.
- Cavallin-Ståhl E, Cohn Cedermark G, Dahl O, Giwercman A, Haugnes HS, Göran Holmberg G, et al. SWENOTECA IX – a cancer care program for seminomatous germ cell tumours. Trondheim: SWENOTECA: Swedish & Norwegian Testicular Cancer group, 2014.
- Angelsen A, Bremnes R, Cavallin-Ståhl E, Dahl O, Giwercman A, Haugnes HS, et al. SWENOTECA VIII – a cancer care program non-seminomatous germ cell tumours (NSGCT). Lund: SWENOTECA group: Swedish & Norwegian Testicular Cancer group, 2012.
- Albers P, Göll A, Bierhoff E, Schoeneich G, Müller SC. Clinical course and histopathologic risk factor assessment in patients with bilateral testicular germ cell tumors. Urology 1999;54:714–18.